1 0 3 1 a r t i c l e s Numerous, often lethal, genetic disorders of bone, cartilage, blood vessels and skin have been linked to defects in the assembly of collagens 1 . In humans, among the 28 different genetic types of collagen 2 , those that form the banded fibrils seen in tissues (types I, II, III, V and XI) are synthesized in a soluble precursor form, procollagen (~450 kDa), with large N-and C-terminal propeptide extensions (50 kDa and 90 kDa, respectively; Fig. 1a ). Inside the cell, assembly of the procollagen molecule from its three polypeptide chains is initiated by association of the C-propeptide domains (otherwise known as COLFI domains), a crucial step in the nucleation and folding of these long rod-like molecules [3] [4] [5] . Although overall sequence homology among C-propeptide domains from different fibrillar procollagens is strong 6 (46% identity among human procollagen types I-III; Fig. 1b) , there is a highly variable discontinuous sequence of 15 amino acids, called the chain recognition sequence (CRS), that seems to confer chain selectivity during assembly of different collagen types within the same cell 7 . This selectivity results in the formation of either homotrimers (procollagens II and III) or heterotrimers (procollagens I, V and XI), each with the correct chain composition (for example, [proα1(I)] 2 proα2(I) for procollagen I or [proα1(III)] 3 for procollagen III), thus preventing the formation of nonphysiological trimers such as [proα2(I)] 3 or hybrid molecules consisting of chains from different collagen types.
Numerous, often lethal, genetic disorders of bone, cartilage, blood vessels and skin have been linked to defects in the assembly of collagens 1 . In humans, among the 28 different genetic types of collagen 2 , those that form the banded fibrils seen in tissues (types I, II, III, V and XI) are synthesized in a soluble precursor form, procollagen (~450 kDa), with large N-and C-terminal propeptide extensions (50 kDa and 90 kDa, respectively; Fig. 1a ). Inside the cell, assembly of the procollagen molecule from its three polypeptide chains is initiated by association of the C-propeptide domains (otherwise known as COLFI domains), a crucial step in the nucleation and folding of these long rod-like molecules [3] [4] [5] . Although overall sequence homology among C-propeptide domains from different fibrillar procollagens is strong 6 (46% identity among human procollagen types I-III; Fig. 1b) , there is a highly variable discontinuous sequence of 15 amino acids, called the chain recognition sequence (CRS), that seems to confer chain selectivity during assembly of different collagen types within the same cell 7 . This selectivity results in the formation of either homotrimers (procollagens II and III) or heterotrimers (procollagens I, V and XI), each with the correct chain composition (for example, [proα1(I)] 2 proα2(I) for procollagen I or [proα1(III)] 3 for procollagen III), thus preventing the formation of nonphysiological trimers such as [proα2(I)] 3 or hybrid molecules consisting of chains from different collagen types.
In addition to its intracellular function in molecular trimerization, another crucial role for the C-propeptide domain is to confer solubility to the collagen molecule, thereby controlling fibril formation 8, 9 (Fig. 1a) . Thus, outside the cell or during intracellular transport and secretion, C-propeptide trimers are released (in the case of procollagens I-III) by BMP-1/tolloid-like proteinases 10 in the ratelimiting step in collagen fibril assembly. C-propeptide cleavage is further regulated by procollagen C-proteinase enhancer proteins, which bind specifically to the C propeptides 11 . Because excess collagen deposition is the hallmark of several fibrotic disorders (affecting heart, lung, liver and so forth) that together are leading causes of morbidity and mortality worldwide 12 , structural data on the C-propeptide trimer are clearly essential for the development of new therapeutic strategies. Free C-propeptide trimers are also involved in feedback inhibition of collagen synthesis 13, 14 , through interaction with integrins 15 , as well as in biomineralization [16] [17] [18] and in angiogenesis and tumor progression 19, 20 . Despite their obvious importance, however, and after many years of research (reviewed in ref. 5) , the three-dimensional structures of C-propeptide domains present throughout the Metazoa 6 have until now remained elusive.
Here we set out to determine the first structure, to our knowledge, of a C-propeptide domain, that of human procollagen III. The results reveal the structural mechanism by which the three polypeptide chains specifically recognize each other during assembly of the procollagen molecule. They also provide unexpected insights into why some types of collagen are homotrimers, whereas others are heterotrimers. Finally, mapping onto the structure the numerous mutation sites associated with heritable connective-tissue disorders affecting bone, cartilage, blood vessels and skin shows striking correlations between three-dimensional localization and phenotype severity. Figure 1c -e shows the three-dimensional structure of the C-propeptide trimer from human procollagen III. It has the overall shape of a flower, consisting of a stalk, a base and three petals. Three structures were determined by X-ray crystallography at 3.5-Å, 2.2-Å and 1.7-Å resolution ( Table 1) . The 3.5-Å structure is the most complete (Fig. 1c-e and stereo version and electron-density map in Supplementary Fig. 1a,b) , showing the stalk, the base and the petals. The stalk comprises the amino acid sequence up to the first conserved proline residue (Pro30; Fig. 1b) . It includes an α-helical coiled coil 21 (helix 1) corresponding to the relatively highly conserved region from residues 12 to 27 (Fig. 1b) .
RESULTS

Structure of the procollagen III C-propeptide trimer
More details (though without the stalk) are shown in the 2.2-Å and 1.7-Å structures (the latter shown in stereo view in Supplementary  Fig. 1c,d ). The base (residues 30-76; Fig. 1b) consists of a disulfidebonded ring connecting all three chains (Supplementary Fig. 1e,f) and includes the first four of the eight cysteines present in each chain. Among the three regions of the molecule, the base is the most highly conserved (60% sequence identity; Fig. 1b) . For each chain, this region begins with an almost perfectly conserved 12-residue loop ending in Cys41, followed by a short α-helix (helix 2) extending to Cys47. A short loop and a two-stranded antiparallel β-sheet follow (strands 1 and 2). The loop connecting strands 1 and 2 (residues 59-68) includes a bound Ca 2+ ion (Supplementary Fig. 1g,h) , as previously suggested from sequence analysis 22 . The structure reveals that this ion has an essential role, stabilizing not only the base region but also the trimer by coordinating a water molecule that is, in turn, hydrogen-bonded to Asp43 in a neighboring chain. One of the Ca 2+ ligands is Cys64, which further stabilizes the trimer by forming the only interchain disulfide bond, with Cys47 in a neighboring chain. In contrast, Cys41 and Cys73 form an intrachain disulfide bond, thus settling the long-standing debate 3 about the roles of these first four cysteines.
Though the base and the petals together form a single entity in the three-dimensional structure, it is convenient to describe the latter as starting between Cys73 and Cys81 (Fig. 1b) . On the outer face of each petal (Fig. 1c) , there is a twisted antiparallel β-sheet, comprising seven β-strands (3, 4, 5, 8, 9, 11 and 12) , which is continuous with that formed by strands 1 and 2 in the base. Notably, strand 12 (at the C terminus), containing Cys243, inserts between strands 3 and 5 and forms an intrachain disulfide bond with Cys81 on strand 3. The C-terminal residue (Leu245) is therefore adjacent to the base as well as to residues involved in chain selectivity. On the inner face of each petal (Fig. 1c) , there is a short antiparallel β-sheet (strands 6, 7 and 10), as well as a short α-helix (helix 3), and the inner and outer faces are connected by an intrachain disulfide bond between Cys151 and Cys196. Further down on the inner face, at the junction with the base, is a relatively long α-helix (helix 4). Almost half the interactions involving the petals implicate residues in and around helix 4 ( Supplementary  Fig. 2) , and the helices 4 of the three subunits form a triangle sitting on the base (Fig. 1e) .
Structural mechanism of chain recognition
Whereas interactions within the base region stabilize the trimer, procollagen chain selectivity is assured by the petals. In particular, the highly variable, discontinuous 15-residue CRS 7 straddles Figure 1 Structure of the C-propeptide trimer of human procollagen III. (a) The C propeptides control both intracellular assembly of procollagen molecules and extracellular assembly of collagen fibrils. Adapted from another paper 33 , with permission. (b) Sequence alignment of the C propeptides of the major human fibrillar procollagen chains. Red, identical residues; pink, similar residues. Different structural regions and secondary structure elements are indicated, as well as cysteine residues (numbered [1] [2] [3] [4] [5] [6] [7] [8] and intrachain disulfide bonds shown as colormatched pairs.
•, residues involved in Ca 2+ coordination; *, the single N-linked glycosylation site. (Asn146 was mutated to glutamate in the structure presented here.) The long (12-residue) and short (3-residue) stretches of the discontinuous 15-residue CRS are outlined in wheat and deep teal, respectively. Numbering refers to the C-propeptides of the proα1(III) chain. Sequence alignments and rendering were done by using CLUSTALW 34 a r t i c l e s helix 4, with its longer 12-residue stretch (residues 120-131) at the N-terminal end and its shorter 3-residue stretch (residues 140-142) at the C-terminal end (Fig. 1b,e) . Although the existence of the CRS has been known for some time, the structural basis of chain recognition has until now remained a mystery. The three-dimensional structure presented here immediately reveals how the CRS controls interchain interactions and in particular exemplifies the need for a discontinuous sequence. As shown in Figures 1d and 2a , residues in the long stretch of the CRS on one chain interact with residues in the short stretch of the CRS on a neighboring chain, revealing an exquisite mechanism of specific chain recognition. Indeed, the structure defines the key specificity-conferring elements within the CRS and also reveals other regions of the molecule involved in chain recognition (Supplementary Fig. 2) . Specifically, interchain interactions include salt bridges between Arg142 (in the CRS short stretch) and Glu126 and Asp130 (both in the CRS long stretch) and between Asp127 (CRS long stretch) and the conserved Arg42 in the base region, as well as between conserved residues (Glu176 with Lys186 and Arg217). When viewed from the side, the interacting surfaces on chains A and B have patches of positive and negative charge, respectively, interacting with patches of opposite charge on chain C (Fig. 2b) . These patches consist of both conserved and variable residues, the latter coming mostly from the CRS (Fig. 2c) .
DISCUSSION
Homotrimers, heterotrimers and other proteins
Close examination of both the 1.7-Å and 2.2-Å structures reveals subtle differences in the conformations of the three polypeptide chains, with one chain differing from the other two, particularly at the C-terminal end of helix 4 (Fig. 3a,b) . Specifically, whereas all three chains generally superimpose well in a structural alignment, chain C bulges out at Leu139 immediately before the short stretch of the CRS. This observation was completely unexpected. Because all three chains have the same amino acid sequence, it might have been assumed that their structures would be identical. Instead, these observations raise the possibility that an intrinsic asymmetry in the structure arises when all three chains pack together. Such asymmetry might account for why, in some types of collagen, molecules have evolved to be heterotrimers (consisting of more than one type of polypeptide chain, as in procollagen I) rather than homotrimers. The presence of a third distinct chain might permit further optimization of packing interactions in the C-propeptide trimer.
The question also arises of how specificity is determined in other procollagen types, both heterotrimers and homotrimers. In procollagen I, we note differences in amino acid sequence in the interaction zone, compared to that of procollagen III, that are consistent with interactions between the proα1(I) and proα2(I) chains (Fig. 3c) . Specifically, the positively charged Arg142 is unique to procollagen III, as are the negatively charged residues Glu126, Asp127 and Asp130. In contrast, Asp127 is replaced by lysine in the proα2(I) chain, whereas Arg142 is replaced by glutamate in the proα1(I) chain. Such changes may contribute to the preferred association of the proα2(I) C propeptide with the proα1(I) C propeptide in procollagen I. Further insights must await the structure determination of other procollagen C-propeptide trimers.
Though the structure of the C-propeptide trimer (excluding the stalk region) shows no obvious similarities with the globular regions of other extracellular trimeric proteins (Supplementary Fig. 3a-e) , detailed comparison using the DALI server 23 revealed some structural similarities with proteins containing the fibrinogen C-terminal domain, including angiopoietin-2, fibrinogens and ficolins. The most striking example is angiopoietin-2 ( Supplementary Fig. 3f ) for which, despite a low sequence identity (<15%; Supplementary Fig. 3g ), most secondary-structure elements are aligned in three dimensions, with the loop regions being much more variable. Structural similarity is particularly strong in the base region and includes a conserved intrachain disulfide bond. Whether this is a result of convergent or divergent evolution is unknown. It has previously been shown, however, that procollagen C-propeptide trimers are involved in tumor vascularization 19, 20 , through effects on endothelial cell migration and induction of vascular endothelial growth factor. This structural similarity with fibrinogen C-terminal domain-containing proteins such as angiopoietin-2 may therefore give insights into the mechanisms of such additional functions of the C propeptides.
Structural basis of related genetic disorders
Fibrillar procollagen C propeptides are associated with several genetic disorders of connective tissues, including different forms of osteogenesis imperfecta (OI; procollagen I), skeletal dysplasias (procollagen II) and two types of Ehlers-Danlos syndrome, type I (affecting mainly skin; procollagen V) and type IV (leading to vascular deficiency; procollagen III). Although hundreds of mutations throughout the length of the collagen molecule have been described 1 , mutations in the C propeptides are particularly important in view of their role in directing the assembly of the procollagen molecule. In general, such mutations can have two Values in parentheses are for highest-resolution shell. n.a., not applicable.
a Four selenomethionine residues were identified in each polypeptide chain. This compares with a total of six methionines in the amino acid sequence, with the remaining two present in the stalk region that was not resolved in forms I and II. These data compare with approximately five selenomethionine residues per chain detected by mass spectrometry 36 . npg a r t i c l e s consequences: either the mutation prevents trimerization completely, leading (in heterozygotes) to haploinsufficiency of the affected collagen type, or the mutation leads to abnormal procollagen assembly, involving both wild-type and mutant chains 1, 24 . In total, 46 missense mutations involving 38 distinct sites have been identified in the C propeptides of the proα1(I), proα2(I), proα1(II), proα1(III) and proα1(V) chains (Supplementary Table 1 and Supplementary Fig. 4) . In most cases, the residue that is mutated in the other procollagen types is conserved in the proα1(III) C-propeptide. This conservation, as well as the strong similarity between the structure presented here and those predicted for the other procollagen types ( Supplementary  Fig. 4 ), permits mapping of these mutations onto the procollagen III C-propeptide structure (Fig. 4 and Supplementary Movie 1) . Mutation sites for the proα2(I) chain are not shown in Figure 4 , as all lead to mild or moderate forms of OI, probably due to substitution by the proα1(I) chain to form the trimer. This mapping allows us to make the following general observations. First, mutations leading to mild to moderate phenotypes (shown in blue or dark blue in Fig. 4 ) generally involve surface-located residues in regions not involved in interchain interactions and are therefore unlikely to interfere with folding or trimerization. The sole exception is the C81W mutation in the proα1(I) chain, which disrupts disulfidebond formation with Cys243 yet leads to a relatively mild OI phenotype (albeit associated, in one case, with fractures of four ribs and a clavicle at birth) and gives rise to delayed trimerization and secretion of procollagen 25 . Second, mutations leading to the most severe phenotypes (shown in red or dark red in Fig. 4 ) are found to be clustered in three regions of the molecule. These include the environment of the C terminus of each chain, at the interface between the petal and the base. Mutations in this region are involved in intrachain disulfide bonding (Cys81-Cys243), interchain interactions (Leu245, Arg137) or stabilization of the hydrophobic core (Leu218). Among these, mutations near the C terminus disrupt trimerization 26 and lead to severe or lethal forms of OI (for example, the L245P mutation in the proα1(I) chain that resulted, in one case, in at least 200 bone fractures before 4 years of age 27 ) or skeletal dysplasia (for example, the C243G mutation in the proα1(II) chain that results in short stature and limbs and leads to death at 22 d from respiratory insufficiency 28 ). In addition, many of the most severe phenotypes are associated with mutations in the region of the Cys151-Cys196 disulfide bond located near the tip of the petals, disrupting either intrachain disulfide bonding or internal hydrophobic interactions. These include, for example, the W94C mutation in the proα1(I) chain, which leads to multiple fractures and perinatal death 29 , or the Y149C mutation in the proα1(II) chain, which also results in perinatal death, due to severe skeletal dysplasia 30 . Finally, other severe or lethal mutations disrupt the base region, Table 1 ). For example, the C41S mutation in the proα1(V) chain disrupts disulfide bonding and leads to Ehlers-Danlos syndrome type I, characterized by skin and joint hyperextensibility as well as poor wound healing 32 . Such mutations underline the essential role of the highly conserved base region in the trimerization of fibrillar procollagens. In summary, here we present the long-awaited structure of the procollagen III C-propeptide trimer, thereby providing a paradigm for this family of protein domains with key implications for human disease. This provides a structural basis for interpreting the effects of new C-propeptide mutations in genetic disorders and also for developing new antifibrotic therapies aimed at disrupting either procollagen trimerization or C-propeptide interactions with other proteins involved in the regulation of collagen fibril formation.
METHODS
Methods and any associated references are available in the online version of the paper. 
